Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/16/2026

1. SPCX
2. SPY
3. ROKU
4. USO
5. HPE
6. CWK
7. VWAV
8. YUM
9. EWTX
10. INTC

Go back to Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
(NASDAQ: CRVS) Delayed: 11.74 -0.16 (1.34%)
Previous Close $11.90    52 Week High $17.77 
Open $12.40    52 Week Low $9.63 
Day High $12.41    P/E N/A 
Day Low $11.67    EPS $0.00 
Volume 1,180,155